UPL Limited

BSE:512070 Rapport sur les actions

Capitalisation boursière : ₹530.2b

UPL Croissance future

Future contrôle des critères 3/6

UPL devrait augmenter ses bénéfices et son chiffre d'affaires de 29.5% et de 7.8% par an respectivement. Le BPA devrait croître de de 30.3% par an. Le rendement des capitaux propres devrait être 10.8% dans 3 ans.

Informations clés

29.5%

Taux de croissance des bénéfices

30.34%

Taux de croissance du BPA

Chemicals croissance des bénéfices19.4%
Taux de croissance des recettes7.8%
Rendement futur des capitaux propres10.80%
Couverture par les analystes

Good

Dernière mise à jour13 May 2026

Mises à jour récentes de la croissance future

Recent updates

Mise à jour du récit • May 18

512070: Upcoming Governance Meetings Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL from ₹811.50 to ₹776.22, citing revised assumptions around profit margins, a higher future P/E multiple, and updated views on discount rates and revenue growth. What's in the News UPL has scheduled an Analyst/Investor Day, providing an opportunity to hear directly from management about the business and capital allocation plans.
Mise à jour du récit • May 01

512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans

Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Mise à jour du récit • Apr 17

512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).
Mise à jour du récit • Apr 03

512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook

Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Mise à jour du récit • Mar 19

512070: Fair Pricing Will Rely On Execution Of Upcoming Restructuring Steps

Analysts have nudged their price target on UPL slightly higher to about ₹648 from roughly ₹641, citing updated assumptions around revenue growth, profit margins, a modestly lower discount rate, and a small adjustment to the expected future P/E multiple. What's in the News UPL has scheduled a board meeting on Feb 02, 2026 at 12:45 Indian Standard Time to consider and approve unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025, along with limited review reports from the statutory auditors (Key Developments).
Mise à jour du récit • Mar 05

512070: Composite Scheme Board Meeting Will Support Stronger Medium Term Outlook

Analysts have raised their price target on UPL by about ₹39 to ₹820, citing updated assumptions that reflect a slightly lower discount rate, a modest tweak to revenue growth and P/E expectations, and a higher projected profit margin. What's in the News Board meeting scheduled for Feb 20, 2026 at 14:30 IST to consider a Composite Scheme of Arrangement involving UPL and its subsidiaries UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited under Sections 230 to 232 and 234 of the Companies Act, 2013 (company filing).
Mise à jour du récit • Feb 18

512070: Revised Margins And Lower P/E Will Likely Struggle To Support Pricing

Analysts have raised their fair value estimate for UPL from ₹600.67 to ₹641.03, citing updated views on the discount rate, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Mise à jour du récit • Feb 04

512070: Higher Margin Assumptions And Upcoming Results Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹944 to ₹975, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News UPL has scheduled a board meeting on Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results.
Mise à jour du récit • Jan 21

512070: Higher Revenue And Margin Assumptions Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹911.93 to ₹944.00 after updating their assumptions for revenue growth, profit margins, discount rate and future P/E. What's in the News UPL has scheduled a Board Meeting on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the statutory auditors (company filing).
Mise à jour du récit • Jan 07

512070: Small Assumption Tweaks Will Likely Fail To Prevent Margin Pressure

Analysts have slightly increased their fair value estimate for UPL from ₹596.98 to ₹600.67. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E multiples.
Mise à jour du récit • Dec 19

512070: Future Margins Will Likely Deteriorate Despite Higher Market Expectations

Analysts have raised their price target for UPL from approximately 526.51 to 596.98, citing slightly stronger expectations for revenue growth and future valuation multiples, partly offset by a more conservative view on profit margins and discount rates. What's in the News UPL Limited has scheduled a board meeting for November 06, 2025 to consider and approve unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from the statutory auditors (company filing).
Mise à jour du récit • Dec 05

512070: Board Meeting And Stable Assumptions Will Shape Medium Term Outlook

Analysts have modestly raised their price target for UPL to ₹781.39, reflecting slightly improved discount rate and future P E assumptions, while largely maintaining their views on growth and profitability. What's in the News A board meeting is scheduled on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Statutory Auditors' limited review reports (company filing).
Mise à jour du récit • Nov 21

512070: Board Meetings And Adjusted Forecasts Will Influence Medium-Term Outlook

Analysts have raised their price target for UPL from $756.34 to $781.39. This reflects optimism driven by slightly improved revenue growth expectations and adjustments to projected profit margins and valuation multiples.
Mise à jour du récit • Nov 07

512070: Upcoming Board Decisions And Steady Financials Will Shape Outlook

Analysts have raised their price target for UPL from $736.09 to $756.34. They cite modest improvements in profit margin and revenue growth forecasts as the reason for this adjustment.
User avatar
Nouveau récit • Dec 10

Biosolutions Innovation And Improved Financial Stability Expected To Boost Earnings Growth

Strategic inventory management and sales mix enhancement are expected to boost margins and improve earnings.

Prévisions de croissance des bénéfices et des revenus

BSE:512070 - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/2029664,43443,52569,53082,8884
3/31/2028606,42342,45966,95988,60115
3/31/2027568,13734,02350,44869,90913
3/31/2026518,39019,22054,49078,550N/A
12/31/2025490,77016,210N/AN/AN/A
9/30/2025477,15020,53060,52077,890N/A
6/30/2025467,86010,570N/AN/AN/A
3/31/2025466,3707,61083,790100,740N/A
12/31/2024451,420-950N/AN/AN/A
9/30/2024441,220-21,40069,33087,980N/A
6/30/2024432,020-18,860N/AN/AN/A
3/31/2024430,980-13,360-1,73018,220N/A
12/31/2023455,890-5,830N/AN/AN/A
9/30/2023493,81017,2103,88026,540N/A
6/30/2023517,18027,240N/AN/AN/A
3/31/2023535,76034,35053,91077,510N/A
12/31/2022528,68040,360N/AN/AN/A
9/30/2022504,86038,85014,92043,170N/A
6/30/2022485,46037,050N/AN/AN/A
3/31/2022462,40035,05038,08064,960N/A
12/31/2021431,75032,200N/AN/AN/A
9/30/2021410,04030,78024,52046,600N/A
6/30/2021393,76029,070N/AN/AN/A
3/31/2021386,94027,81050,90072,120N/A
12/31/2020370,39024,250N/AN/AN/A
9/30/2020368,05023,39053,29073,610N/A
6/30/2020356,83020,420N/AN/AN/A
3/31/2020357,56017,76067,59087,390N/A
12/31/2019331,40013,650N/AN/AN/A
9/30/2019291,6909,340N/A40,010N/A
6/30/2019256,09011,150N/AN/AN/A
3/31/2019218,37014,910N/A23,560N/A
12/31/2018190,03019,770N/AN/AN/A
9/30/2018182,76020,900N/AN/AN/A
6/30/2018177,89020,590N/AN/AN/A
3/31/2018173,78020,220N/A28,360N/A
12/31/2017170,29020,270N/AN/AN/A
9/30/2017167,54019,120N/AN/AN/A
6/30/2017165,25018,400N/AN/AN/A
3/31/2017163,12017,270N/A25,850N/A
12/31/2016146,18015,473N/AN/AN/A
9/30/2016140,16313,692N/AN/AN/A
6/30/2016135,36613,840N/AN/AN/A
3/31/2016140,4809,400N/A13,960N/A
12/31/2015125,86111,913N/AN/AN/A
9/30/2015125,37011,538N/AN/AN/A
6/30/2015123,97811,347N/AN/AN/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 512070 ( 29.5% par an) est supérieure au taux d'épargne ( 6.9% ).

Bénéfices vs marché: Les bénéfices de 512070 ( 29.5% par an) devraient croître plus rapidement que le marché Indian ( 16.4% par an).

Croissance élevée des bénéfices: Les bénéfices de 512070 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 512070 ( 7.8% par an) devrait croître plus lentement que le marché de Indian ( 10.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 512070 ( 7.8% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 512070 devrait être faible dans 3 ans ( 10.8 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/21 18:41
Cours de l'action en fin de journée2026/05/21 00:00
Les revenus2026/03/31
Revenus annuels2026/03/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

UPL Limited est couverte par 40 analystes. 17 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
null null360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited